Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchXAV-19XAV-19 (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial

Gaborit et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofad525, POLYCOR, NCT04453384, Oct 2023
https://c19early.org/gaborit.html
Mortality, day 60 -90% Improvement Relative Risk Mortality, day 15 5% Ventilation -106% ICU admission -5% Progression -5% XAV-19  POLYCOR  LATE TREATMENT  DB RCT Is late treatment with XAV-19 beneficial for COVID-19? Double-blind RCT 398 patients in France (January - April 2021) Higher ventilation with XAV-19 (p=0.027) c19early.org Gaborit et al., Open Forum Infectious .., Oct 2023 FavorsXAV-19 Favorscontrol 0 0.5 1 1.5 2+
RCT 398 hospitalized patients with severe COVID-19 requiring low-flow oxygen therapy showing no significant difference in death or respiratory failure through day 15 with XAV-19 (a swine glyco-humanized polyclonal neutralizing antibody) compared to placebo.
risk of death, 89.9% higher, RR 1.90, p = 0.29, treatment 10 of 199 (5.0%), control 5 of 189 (2.6%), day 60.
risk of death, 5.0% lower, RR 0.95, p = 1.00, treatment 3 of 199 (1.5%), control 3 of 189 (1.6%), NNT 1254, day 15.
risk of mechanical ventilation, 105.8% higher, RR 2.06, p = 0.03, treatment 26 of 199 (13.1%), control 12 of 189 (6.3%), day 29.
risk of ICU admission, 5.0% higher, RR 1.05, p = 0.90, treatment 42 of 199 (21.1%), control 38 of 189 (20.1%), day 29.
risk of progression, 4.9% higher, RR 1.05, p = 0.82, treatment 53 of 199 (26.6%), control 48 of 189 (25.4%), death or respitatory failure.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Gaborit et al., 20 Oct 2023, Double Blind Randomized Controlled Trial, placebo-controlled, France, peer-reviewed, mean age 59.8, 18 authors, study period 12 January, 2021 - 16 April, 2021, average treatment delay 8.5 days, trial NCT04453384 (history) (POLYCOR). Contact: benjamin.gaborit@chunantes.fr, francois.raffi@chu-nantes.fr.
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial
MD Benjamin Gaborit, Bernard Vanhove, Karine Lacombe, Thomas Guimard, Laurent Hocqueloux, Ludivine Perrier, Vincent Dubee, Virginie Ferre, Celine Bressollette, Régis Josien, Aurélie Le Thuaut, Marie-Anne Vibet, Alexandra Jobert, Eric Dailly, Florence Ader, Sophie Brouard, Odile Duvaux, MD François Raffi, MD Benjamin Gaborit, MD François Raffi, Maeva Lefebvre, Charlotte Biron, Raphaël Lecomte, Cécile Braudeau, Marie Chauveau, Eric Dailly, Colin Deschanvres, Matthieu Gregoire, Anne-Sophie Lecomte, Laurent Flet, Martine Tching-Sin, Eugenie Clapeau, Jérémie Orain, Morgane Le Bras, Alexandre Duval, Isabelle Portier, Clara Mora, Anne-Sophie Boureau, Etienne Seronie-Doutriaux, Agnès Rouaud, Pamela Hublain, Laurence Le Jumeau De Kergaradec, Carole Agasse, Vivien Danielo, Megguy Bernard, Régine Valero, Karine Lacombe, Diane Bollens, Thibault Chiarabini, Nadia Valin, Patrick Ingiliz, Zineb Ouazene, Bénédicte Lefebvre, François Lecardonnel, Christian Tran, Raynald Feliho, Manuela Le Cam, Julie Lamarque, Jean-Luc Lagneau, Cyrielle Letaillandier, Anne Daguenel-Nguyen, Clémentine Mayala-Kanda, Djeneba Fofana, Arianna Fiorentino, Thomas Guimard, Yves Bleher, Jean-Luc Esnault, Dominique Merrien, Blandine Le Claire, Marine Morrier, Delphine Boucher, Romain Lamberet, Clémentine Coudon, Romain Decours, Hélène Durand, Armelle Pegeot, Edwige Migne, Hélène Pelerin, Yannick Poirier, Laurent Hocqueloux, Thierry Prazuck, Barbara De Dieuleveult, Pierre Plocco, Jérôme Guinard, Elisa Demonchy, Eric Cua, Edouard Devaud, Stanislas Harent, Marion Parisey, Céleste Lambert, Elise Gobin, Julien Manson, Pierre Pasquier, Pascale Martres, Patricia Kessedjian, Hikombo Hitoto, Nicolas Crochette, Lucia Perez-Grandiere, Jean-Baptiste Laine, Arnaud Salmon-Rousseau, Guillaume Cosseron, Sophie Blanchi, Florence Ader, Valérie Galvan, Alexia Moulin, Corinne Brochier, Julianne Oddone, Maude Bouscambert-Duchamp, Firouzé Bani-Sadr, Yohan N’guyen, Maxime Hentzien, Cédric Castex, Philippe Benoit, Véronique Brodard, Didier Laureillard, Albert Sotto, Paul Loubet, Aurélie Martin, Régine Doncesco, Julien Mazet, Ian Soulairol, Robin Stephan, François Goehringer, Nathalie Thilly, Michel Prevot, Hélène Jeulin, Jean-Philippe Talarmin, Lydie Khatchatourian, Nadia Saidan, Brice Guerpillon, Pascaline Rameau, Nicolas Cassou, Thomas Briand, Florence Le Gall, Elodie Le Breton, Cédric Joseph, Sandrine Soriot-Thomas, Claire Andrejak, Jean-Philippe Lanoix, Sophie Boddaert, Sandrine Castelain, Vincent Pestre, Juliette Woessner, Sophie Bayle, Stéphanie Branger, Christine Christides, Philippe Bielefeld, Adèle Lacroix, Roselyne Pillard-Gagliano, Isabelle Trinh, Pierre Lafitte, Guillermo Giordano, Malena Finello, Ignacio Ledesma, Gustavo Martini, Benjamin Delafontaine, Iris Corus, Pierre Baby, Emilie Catherinot, Céline Goyard, Simon Chauveau, Jad Choucair, Beatrice D’urso, Marie Da Silva Costa, Lucie Le Meur, Marc Vasse, Tiffany Pascreau, Eric Farfour, Benjamin Dervieux, C Charlotte Kaeuffer, François Danion, Yves Hansmann, Nicolas Lefebvre, Yvon Ruch, Axel Ursenbach, Catherine Schmidt-Mutter, Muhtadi Suliman, Anne Hutt, Guillaume Becker, Elodie Laugel, Sophie Bayer, Vincent Dubee, Rafael Mahieu, Valérie Daniel, Caroline Lefeuvre, Alexandra Ducancelle, Jean-Charles Gagnard, Abolfzl Mohebbi, Mélanie Dehais, Sophie Raccah, Anne-Lise Pouliquen, Alison Klasen, Emmanuel Forestier, Marie-Christine Carret, Severine Liardot, Jérôme Grosjean, Jean-François Faucher, Josselin Brisset, Anne Cypierre, Hélène Durox, Pauline Pinet, Sophie Ducroix-Roubertou, Claire Genet, Christine Vallejo, Sébastien Hantz, Marie Gousseff, Antoine Merlet, Sébastien Bigot, Marion Girard De Courtilles, Pascal Pouedras, Delphine Lariviere, Renaud Verdon, Sylvie Dargere, Jocelyn Michon, Anna Fournier, Sylvie Brucato, Séverine Gautier, Cécile Valentin, Anne Ricci, Antoine Alix, Flore Lacassin-Beller, Sophie Rousseau, Jérôme Dimet, Anne-Hélène Boivin, Maylis Larregle, Guillaume Rousseau, Ady Assaf, Fanny Vuotto, Karine Faure, Camille Joachim, Laurence Bocket, Kévin Diallo, Jessy Saffore, Isabelle Madeline, Pauline Chabanon, Nathalie Allou, Elisabeth Fernandes, Anne-Sophie Gruliere, Elisabeth Botelho-Nevers, Amandine Gagneux-Brunon, Véronique Ronat, Nadine Casimir, Sylvie Pillet, Frédérique Bertholon, Gilles Pialloux, Marwa Bachir Elrufaai, Ruxandra Calin, Pélagie Thibaut, Fatima Tendjaoui, Julie Fillon
Open Forum Infectious Diseases, doi:10.1093/ofid/ofad525
Background. We evaluated the safety and efficacy of XAV-19, an antispike glyco-humanized swine polyclonal neutralizing antibody in patients hospitalized with severe coronavirus disease 2019 . Methods. This phase 2b clinical trial enrolled adult patients from 34 hospitals in France. Eligible patients had a confirmed diagnosis of severe acute respiratory syndrome coronavirus 2 within 14 days of onset of symptoms that required hospitalization for low-flow oxygen therapy (<6 L/min of oxygen). Patients were randomly assigned to receive a single intravenous infusion of 2 mg/kg of XAV-19 or placebo. The primary end point was the occurrence of death or severe respiratory failure between baseline and day 15. Results. Between January 12, 2021, and April 16, 2021, 398 patients were enrolled in the study and randomly assigned to XAV-19 or placebo. The modified intention-to-treat population comprised 388 participants who received full perfusion of XAV-19 (199 patients) or placebo (189 patients). The mean (SD) age was 59.8 (12.4) years, 249 (64.2%) individuals were men, and the median time (interquartile range) from symptom onset to enrollment was 9 (7-10) days. There was no statistically significant decrease in the cumulative incidence of death or severe respiratory failure through day 15 in the XAV-19 group vs the placebo group (53/199 [26.6%] vs 48/189 [25.4%]; adjusted risk difference, 0.6%; 95% CI, -6% to 7%; hazard ratio, 1.03; 95% CI, 0.64-1.66; P = .90). In the safety population, adverse events were reported in 75.4% of 199 patients in the XAV-19 group and in 76.3% of 190 patients in the placebo group through D29. Conclusions. Among patients hospitalized with COVID-19 requiring low-flow oxygen therapy, treatment with a single intravenous dose of XAV-19, compared with placebo, did not show a significant difference in terms of disease progression at day 15.
Supplementary Data Supplementary materials are available at Open Forum Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author. Notes Acknowledgments. The POLYCOR trial was supported by the Comité ad hoc de Pilotage National des Essais Thérapeutiques et Autres Recherches sur le COVID-19 (CAPNET, label Priorité Nationale de Recherche-National Research Priority). We thank the Biological Resource Centre for Biobanking (CHU Nantes, Nantes Université, Centre de Resources Biologiques [BB-0033_00040], Nantes, France). We thank the clinical and research teams as well as the pharmacists and virologists at all the participating clinical centers who contributed to the management of the study patients for their commitment to providing optimal patient care. Financial support. The POLYCOR study was funded and fully supported by the University Hospital of Nantes with support from the Bpifrance (Banque Publique d'Investissement) (BPI France) in the framework of the Investment for the Future Program (Programme d'Investissements d'Avenir) and Xenothera. Role of the funder/sponsor. Nantes University Hospital Research Department was the sponsor of the study. The funders of the study had no role in study conduct, data collection, or data analysis. Nantes University Hospital, BPI France, and..
References
Ader, Bouscambert-Duchamp, Hites, Peiffer-Smadja, Mentré et al., Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19, Lancet Infect Dis
Ader, Bouscambert-Duchamp, Hites, Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial, Lancet Infect Dis
Agarwal, Rochwerg, Lamontagne, A living WHO guideline on drugs for COVID-19, BMJ
Albuquerque, Eckert, Tramujas, Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis, Clin Microbiol Infect
Butt, Yan, Shaikh, Talisa, Omer et al., Nirmatrelvir/ritonavir use and hospitalizations or death in previously uninfected non-hospitalized high-risk population with COVID-19: a matched cohort study, J Infect Dis, doi:10.1093/infdis/jiad393
Casadevall, Dadachova, Pirofski, Passive antibody therapy for infectious diseases, Nat Rev Microbiol
Chigutsa, 'brien, Sells, Long, Chien, Population pharmacokinetics and pharmacodynamics of the neutralizing antibodies bamlanivimab and etesevimab in patients with mild to moderate COVID-19 infection, Clin Pharmacol Ther
Gaborit, Dailly, Vanhove, Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebocontrolled, phase IIa study, Antimicrob Agents Chemother
Gaborit, Vanhove, Vibet, Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial, Trials
Group, Horby, Lim, Dexamethasone in hospitalized patients with COVID-19, N Engl J Med
Guimarães, Quirk, Furtado, Tofacitinib in patients hospitalized with COVID-19 pneumonia, N Engl J Med
Gupta, Gonzalez-Rojas, Juarez, Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial, JAMA
Huygens, Munnink, Gharbharan, Koopmans, Rijnders, Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the severe acute respiratory syndrome coronavirus 2 Omicron variant, Clin Infect Dis
Iannizzi, Chai, Piechotta, Convalescent plasma for people with COVID-19: a living systematic review, Cochrane Database Syst Rev
Jadhav, Khaowroongrueng, Fueth, Otteneder, Richter et al., Tissue distribution of a therapeutic monoclonal antibody determined by large pore microdialysis, J Pharm Sci
Lustig, Zuckerman, Nemet, Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel, Euro Surveill
Moores, Tritschler, Brosnahan, Thromboprophylaxis in patients with COVID-19: a brief update to the CHEST guideline and expert panel report, Chest
Self, Wheeler, Stewart, Neutralizing COVID-19 convalescent plasma in adults hospitalized with COVID-19: a blinded, randomized, placebocontrolled trial, Chest
Shah, Betts, Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human, mAbs
Sterne, Murthy, Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis, JAMA
Tan, Chia, Qin, A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction, Nat Biotechnol
Van Laethem, Baus, Smyth, Glucocorticoids attenuate T cell receptor signaling, J Exp Med
Vanhove, Duvaux, Rousse, High neutralizing potency of swine glycohumanized polyclonal antibodies against SARS-CoV-2, Eur J Immunol
Vanhove, Marot, Evanno, Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron), doi:10.1101/2022.01.26.477856v1
Vanhove, Marot, So, XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants, Front Immunol
Weinreich, Sivapalasingam, Norton, REGEN-COV antibody combination and outcomes in outpatients with COVID-19, N Engl J Med
Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA
DOI record: { "DOI": "10.1093/ofid/ofad525", "ISSN": [ "2328-8957" ], "URL": "http://dx.doi.org/10.1093/ofid/ofad525", "abstract": "<jats:title>Abstract</jats:title>\n <jats:sec>\n <jats:title>Background</jats:title>\n <jats:p>We evaluated the safety and efficacy of XAV-19, an antispike glyco-humanized swine polyclonal neutralizing antibody in patients hospitalized with severe coronavirus disease 2019 (COVID-19).</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Methods</jats:title>\n <jats:p>This phase 2b clinical trial enrolled adult patients from 34 hospitals in France. Eligible patients had a confirmed diagnosis of severe acute respiratory syndrome coronavirus 2 within 14 days of onset of symptoms that required hospitalization for low-flow oxygen therapy (&amp;lt;6 L/min of oxygen). Patients were randomly assigned to receive a single intravenous infusion of 2 mg/kg of XAV-19 or placebo. The primary end point was the occurrence of death or severe respiratory failure between baseline and day 15.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Results</jats:title>\n <jats:p>Between January 12, 2021, and April 16, 2021, 398 patients were enrolled in the study and randomly assigned to XAV-19 or placebo. The modified intention-to-treat population comprised 388 participants who received full perfusion of XAV-19 (199 patients) or placebo (189 patients). The mean (SD) age was 59.8 (12.4) years, 249 (64.2%) individuals were men, and the median time (interquartile range) from symptom onset to enrollment was 9 (7–10) days. There was no statistically significant decrease in the cumulative incidence of death or severe respiratory failure through day 15 in the XAV-19 group vs the placebo group (53/199 [26.6%] vs 48/189 [25.4%]; adjusted risk difference, 0.6%; 95% CI, −6% to 7%; hazard ratio, 1.03; 95% CI, 0.64–1.66; P = .90). In the safety population, adverse events were reported in 75.4% of 199 patients in the XAV-19 group and in 76.3% of 190 patients in the placebo group through D29.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Conclusions</jats:title>\n <jats:p>Among patients hospitalized with COVID-19 requiring low-flow oxygen therapy, treatment with a single intravenous dose of XAV-19, compared with placebo, did not show a significant difference in terms of disease progression at day 15.</jats:p>\n </jats:sec>", "author": [ { "ORCID": "http://orcid.org/0000-0002-6076-9722", "affiliation": [ { "name": "Nantes Université, CHU Nantes, INSERM, Department of Infectious Diseases , Nantes , France" }, { "name": "Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology , Nantes , France" } ], "authenticated-orcid": false, "family": "Gaborit", "given": "Benjamin", "sequence": "first" }, { "affiliation": [ { "name": "Xenothera , Nantes , France" } ], "family": "Vanhove", "given": "Bernard", "sequence": "additional" }, { "affiliation": [ { "name": "INSERM, AP-HP, Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université , Paris , France" } ], "family": "Lacombe", "given": "Karine", "sequence": "additional" }, { "affiliation": [ { "name": "Infectious Diseases and Emergency Department, Centre Hospitalier de La Roche sur Yon , La Roche sur Yon , France" } ], "family": "Guimard", "given": "Thomas", "sequence": "additional" }, { "affiliation": [ { "name": "CHU d’Orléans, Department of Infectious Diseases , Orleans , France" } ], "family": "Hocqueloux", "given": "Laurent", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, Sponsor Department, Direction de la Recherche et de l’Innovation , Nantes , France" } ], "family": "Perrier", "given": "Ludivine", "sequence": "additional" }, { "affiliation": [ { "name": "Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire d'Angers , Angers , France" }, { "name": "Univ Angers, Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT , Angers , France" } ], "family": "Dubee", "given": "Vincent", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, Virology Laboratory , Nantes , France" } ], "family": "Ferre", "given": "Virginie", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, Virology Laboratory , Nantes , France" } ], "family": "Bressollette", "given": "Celine", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology , Nantes , France" }, { "name": "Nantes Université, CHU Nantes, Laboratoire d’Immunologie, CIMNA , Nantes , France" } ], "family": "Josien", "given": "Régis", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, Sponsor Department, Direction de la Recherche et de l’Innovation , Nantes , France" }, { "name": "Nantes Université, CHU Nantes, Plateforme de Méthodologie et Biostatistique, Direction de la Recherche et de l’Innovation , Nantes , France" } ], "family": "Thuaut", "given": "Aurélie Le", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, Sponsor Department, Direction de la Recherche et de l’Innovation , Nantes , France" }, { "name": "Nantes Université, CHU Nantes, Plateforme de Méthodologie et Biostatistique, Direction de la Recherche et de l’Innovation , Nantes , France" } ], "family": "Vibet", "given": "Marie-Anne", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, Sponsor Department, Direction de la Recherche et de l’Innovation , Nantes , France" }, { "name": "Nantes Université, CHU Nantes, UMR 1246 MethodS in Patients-centered outcomes and HEalth Research,” SPHERE , Nantes , France" } ], "family": "Jobert", "given": "Alexandra", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, Clinical Pharmacology Department , Nantes , France" } ], "family": "Dailly", "given": "Eric", "sequence": "additional" }, { "affiliation": [ { "name": "CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Centre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, Université Lyon , Lyon , France" }, { "name": "Département des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon , Lyon , France" } ], "family": "Ader", "given": "Florence", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology , Nantes , France" } ], "family": "Brouard", "given": "Sophie", "sequence": "additional" }, { "affiliation": [ { "name": "Xenothera , Nantes , France" } ], "family": "Duvaux", "given": "Odile", "sequence": "additional" }, { "affiliation": [ { "name": "Nantes Université, CHU Nantes, INSERM, Department of Infectious Diseases , Nantes , France" } ], "family": "Raffi", "given": "François", "sequence": "additional" }, { "affiliation": [], "family": "Gaborit", "given": "Benjamin", "sequence": "additional" }, { "affiliation": [], "family": "Raffi", "given": "François", "sequence": "additional" }, { "affiliation": [], "family": "Lefebvre", "given": "Maeva", "sequence": "additional" }, { "affiliation": [], "family": "Biron", "given": "Charlotte", "sequence": "additional" }, { "affiliation": [], "family": "Lecomte", "given": "Raphaël", "sequence": "additional" }, { "affiliation": [], "family": "Braudeau", "given": "Cécile", "sequence": "additional" }, { "affiliation": [], "family": "Chauveau", "given": "Marie", "sequence": "additional" }, { "affiliation": [], "family": "Dailly", "given": "Eric", "sequence": "additional" }, { "affiliation": [], "family": "Deschanvres", "given": "Colin", "sequence": "additional" }, { "affiliation": [], "family": "Gregoire", "given": "Matthieu", "sequence": "additional" }, { "affiliation": [], "family": "Lecomte", "given": "Anne-sophie", "sequence": "additional" }, { "affiliation": [], "family": "Flet", "given": "Laurent", "sequence": "additional" }, { "affiliation": [], "family": "Tching-Sin", "given": "Martine", "sequence": "additional" }, { "affiliation": [], "family": "Clapeau", "given": "Eugenie", "sequence": "additional" }, { "affiliation": [], "family": "Orain", "given": "Jérémie", "sequence": "additional" }, { "affiliation": [], "family": "Le Bras", "given": "Morgane", "sequence": "additional" }, { "affiliation": [], "family": "Duval", "given": "Alexandre", "sequence": "additional" }, { "affiliation": [], "family": "Portier", "given": "Isabelle", "sequence": "additional" }, { "affiliation": [], "family": "Mora", "given": "Clara", "sequence": "additional" }, { "affiliation": [], "family": "Boureau", "given": "Anne-Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Seronie-Doutriaux", "given": "Etienne", "sequence": "additional" }, { "affiliation": [], "family": "Rouaud", "given": "Agnès", "sequence": "additional" }, { "affiliation": [], "family": "Hublain", "given": "Pamela", "sequence": "additional" }, { "affiliation": [], "family": "Le Jumeau De Kergaradec", "given": "Laurence", "sequence": "additional" }, { "affiliation": [], "family": "Agasse", "given": "Carole", "sequence": "additional" }, { "affiliation": [], "family": "Danielo", "given": "Vivien", "sequence": "additional" }, { "affiliation": [], "family": "Bernard", "given": "Megguy", "sequence": "additional" }, { "affiliation": [], "family": "Valero", "given": "Régine", "sequence": "additional" }, { "affiliation": [], "family": "Lacombe", "given": "Karine", "sequence": "additional" }, { "affiliation": [], "family": "Bollens", "given": "Diane", "sequence": "additional" }, { "affiliation": [], "family": "Chiarabini", "given": "Thibault", "sequence": "additional" }, { "affiliation": [], "family": "Valin", "given": "Nadia", "sequence": "additional" }, { "affiliation": [], "family": "Ingiliz", "given": "Patrick", "sequence": "additional" }, { "affiliation": [], "family": "Ouazene", "given": "Zineb", "sequence": "additional" }, { "affiliation": [], "family": "Lefebvre", "given": "Bénédicte", "sequence": "additional" }, { "affiliation": [], "family": "Lecardonnel", "given": "François", "sequence": "additional" }, { "affiliation": [], "family": "Tran", "given": "Christian", "sequence": "additional" }, { "affiliation": [], "family": "Feliho", "given": "Raynald", "sequence": "additional" }, { "affiliation": [], "family": "Le Cam", "given": "Manuela", "sequence": "additional" }, { "affiliation": [], "family": "Lamarque", "given": "Julie", "sequence": "additional" }, { "affiliation": [], "family": "Lagneau", "given": "Jean-Luc", "sequence": "additional" }, { "affiliation": [], "family": "Letaillandier", "given": "Cyrielle", "sequence": "additional" }, { "affiliation": [], "family": "Daguenel-Nguyen", "given": "Anne", "sequence": "additional" }, { "affiliation": [], "family": "Mayala-Kanda", "given": "Clémentine", "sequence": "additional" }, { "affiliation": [], "family": "Fofana", "given": "Djeneba", "sequence": "additional" }, { "affiliation": [], "family": "Fiorentino", "given": "Arianna", "sequence": "additional" }, { "affiliation": [], "family": "Guimard", "given": "Thomas", "sequence": "additional" }, { "affiliation": [], "family": "Bleher", "given": "Yves", "sequence": "additional" }, { "affiliation": [], "family": "Esnault", "given": "Jean-Luc", "sequence": "additional" }, { "affiliation": [], "family": "Merrien", "given": "Dominique", "sequence": "additional" }, { "affiliation": [], "family": "Le Claire", "given": "Blandine", "sequence": "additional" }, { "affiliation": [], "family": "Morrier", "given": "Marine", "sequence": "additional" }, { "affiliation": [], "family": "Boucher", "given": "Delphine", "sequence": "additional" }, { "affiliation": [], "family": "Lamberet", "given": "Romain", "sequence": "additional" }, { "affiliation": [], "family": "Coudon", "given": "Clémentine", "sequence": "additional" }, { "affiliation": [], "family": "Decours", "given": "Romain", "sequence": "additional" }, { "affiliation": [], "family": "Durand", "given": "Hélène", "sequence": "additional" }, { "affiliation": [], "family": "Pegeot", "given": "Armelle", "sequence": "additional" }, { "affiliation": [], "family": "Migne", "given": "Edwige", "sequence": "additional" }, { "affiliation": [], "family": "Pelerin", "given": "Hélène", "sequence": "additional" }, { "affiliation": [], "family": "Poirier", "given": "Yannick", "sequence": "additional" }, { "affiliation": [], "family": "Hocqueloux", "given": "Laurent", "sequence": "additional" }, { "affiliation": [], "family": "Prazuck", "given": "Thierry", "sequence": "additional" }, { "affiliation": [], "family": "De Dieuleveult", "given": "Barbara", "sequence": "additional" }, { "affiliation": [], "family": "Plocco", "given": "Pierre", "sequence": "additional" }, { "affiliation": [], "family": "Guinard", "given": "Jérôme", "sequence": "additional" }, { "affiliation": [], "family": "Demonchy", "given": "Elisa", "sequence": "additional" }, { "affiliation": [], "family": "Cua", "given": "Eric", "sequence": "additional" }, { "affiliation": [], "family": "Devaud", "given": "Edouard", "sequence": "additional" }, { "affiliation": [], "family": "Harent", "given": "Stanislas", "sequence": "additional" }, { "affiliation": [], "family": "Parisey", "given": "Marion", "sequence": "additional" }, { "affiliation": [], "family": "Lambert", "given": "Céleste", "sequence": "additional" }, { "affiliation": [], "family": "Gobin", "given": "Elise", "sequence": "additional" }, { "affiliation": [], "family": "Manson", "given": "Julien", "sequence": "additional" }, { "affiliation": [], "family": "Pasquier", "given": "Pierre", "sequence": "additional" }, { "affiliation": [], "family": "Martres", "given": "Pascale", "sequence": "additional" }, { "affiliation": [], "family": "Kessedjian", "given": "Patricia", "sequence": "additional" }, { "affiliation": [], "family": "Hitoto", "given": "Hikombo", "sequence": "additional" }, { "affiliation": [], "family": "Crochette", "given": "Nicolas", "sequence": "additional" }, { "affiliation": [], "family": "Perez-Grandiere", "given": "Lucia", "sequence": "additional" }, { "affiliation": [], "family": "Laine", "given": "Jean-Baptiste", "sequence": "additional" }, { "affiliation": [], "family": "Salmon-Rousseau", "given": "Arnaud", "sequence": "additional" }, { "affiliation": [], "family": "Cosseron", "given": "Guillaume", "sequence": "additional" }, { "affiliation": [], "family": "Blanchi", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Ader", "given": "Florence", "sequence": "additional" }, { "affiliation": [], "family": "Galvan", "given": "Valérie", "sequence": "additional" }, { "affiliation": [], "family": "Moulin", "given": "Alexia", "sequence": "additional" }, { "affiliation": [], "family": "Brochier", "given": "Corinne", "sequence": "additional" }, { "affiliation": [], "family": "Oddone", "given": "Julianne", "sequence": "additional" }, { "affiliation": [], "family": "Bouscambert-Duchamp", "given": "Maude", "sequence": "additional" }, { "affiliation": [], "family": "Bani-Sadr", "given": "Firouzé", "sequence": "additional" }, { "affiliation": [], "family": "N’guyen", "given": "Yohan", "sequence": "additional" }, { "affiliation": [], "family": "Hentzien", "given": "Maxime", "sequence": "additional" }, { "affiliation": [], "family": "Castex", "given": "Cédric", "sequence": "additional" }, { "affiliation": [], "family": "Benoit", "given": "Philippe", "sequence": "additional" }, { "affiliation": [], "family": "Brodard", "given": "Véronique", "sequence": "additional" }, { "affiliation": [], "family": "Laureillard", "given": "Didier", "sequence": "additional" }, { "affiliation": [], "family": "Sotto", "given": "Albert", "sequence": "additional" }, { "affiliation": [], "family": "Loubet", "given": "Paul", "sequence": "additional" }, { "affiliation": [], "family": "Martin", "given": "Aurélie", "sequence": "additional" }, { "affiliation": [], "family": "Doncesco", "given": "Régine", "sequence": "additional" }, { "affiliation": [], "family": "Mazet", "given": "Julien", "sequence": "additional" }, { "affiliation": [], "family": "Soulairol", "given": "Ian", "sequence": "additional" }, { "affiliation": [], "family": "Stephan", "given": "Robin", "sequence": "additional" }, { "affiliation": [], "family": "Goehringer", "given": "François", "sequence": "additional" }, { "affiliation": [], "family": "Thilly", "given": "Nathalie", "sequence": "additional" }, { "affiliation": [], "family": "Prevot", "given": "Michel", "sequence": "additional" }, { "affiliation": [], "family": "Jeulin", "given": "Hélène", "sequence": "additional" }, { "affiliation": [], "family": "Talarmin", "given": "Jean-Philippe", "sequence": "additional" }, { "affiliation": [], "family": "Khatchatourian", "given": "Lydie", "sequence": "additional" }, { "affiliation": [], "family": "Saidan", "given": "Nadia", "sequence": "additional" }, { "affiliation": [], "family": "Guerpillon", "given": "Brice", "sequence": "additional" }, { "affiliation": [], "family": "Rameau", "given": "Pascaline", "sequence": "additional" }, { "affiliation": [], "family": "Cassou", "given": "Nicolas", "sequence": "additional" }, { "affiliation": [], "family": "Briand", "given": "Thomas", "sequence": "additional" }, { "affiliation": [], "family": "Le Gall", "given": "Florence", "sequence": "additional" }, { "affiliation": [], "family": "Le Breton", "given": "Elodie", "sequence": "additional" }, { "affiliation": [], "family": "Joseph", "given": "Cédric", "sequence": "additional" }, { "affiliation": [], "family": "Soriot-Thomas", "given": "Sandrine", "sequence": "additional" }, { "affiliation": [], "family": "Andrejak", "given": "Claire", "sequence": "additional" }, { "affiliation": [], "family": "Lanoix", "given": "Jean-Philippe", "sequence": "additional" }, { "affiliation": [], "family": "Boddaert", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Castelain", "given": "Sandrine", "sequence": "additional" }, { "affiliation": [], "family": "Pestre", "given": "Vincent", "sequence": "additional" }, { "affiliation": [], "family": "Woessner", "given": "Juliette", "sequence": "additional" }, { "affiliation": [], "family": "Bayle", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Branger", "given": "Stéphanie", "sequence": "additional" }, { "affiliation": [], "family": "Christides", "given": "Christine", "sequence": "additional" }, { "affiliation": [], "family": "Bielefeld", "given": "Philippe", "sequence": "additional" }, { "affiliation": [], "family": "Lacroix", "given": "Adèle", "sequence": "additional" }, { "affiliation": [], "family": "Pillard-Gagliano", "given": "Roselyne", "sequence": "additional" }, { "affiliation": [], "family": "Trinh", "given": "Isabelle", "sequence": "additional" }, { "affiliation": [], "family": "Lafitte", "given": "Pierre", "sequence": "additional" }, { "affiliation": [], "family": "Giordano", "given": "Guillermo", "sequence": "additional" }, { "affiliation": [], "family": "Finello", "given": "Malena", "sequence": "additional" }, { "affiliation": [], "family": "Ledesma", "given": "Ignacio", "sequence": "additional" }, { "affiliation": [], "family": "Martini", "given": "Gustavo", "sequence": "additional" }, { "affiliation": [], "family": "Delafontaine", "given": "Benjamin", "sequence": "additional" }, { "affiliation": [], "family": "Corus", "given": "Iris", "sequence": "additional" }, { "affiliation": [], "family": "Baby", "given": "Pierre", "sequence": "additional" }, { "affiliation": [], "family": "Catherinot", "given": "Emilie", "sequence": "additional" }, { "affiliation": [], "family": "Goyard", "given": "Céline", "sequence": "additional" }, { "affiliation": [], "family": "Chauveau", "given": "Simon", "sequence": "additional" }, { "affiliation": [], "family": "Choucair", "given": "Jad", "sequence": "additional" }, { "affiliation": [], "family": "D’urso", "given": "Beatrice", "sequence": "additional" }, { "affiliation": [], "family": "Da Silva Costa", "given": "Marie", "sequence": "additional" }, { "affiliation": [], "family": "Le Meur", "given": "Lucie", "sequence": "additional" }, { "affiliation": [], "family": "Vasse", "given": "Marc", "sequence": "additional" }, { "affiliation": [], "family": "Pascreau", "given": "Tiffany", "sequence": "additional" }, { "affiliation": [], "family": "Farfour", "given": "Eric", "sequence": "additional" }, { "affiliation": [], "family": "Dervieux", "given": "Benjamin", "sequence": "additional" }, { "affiliation": [], "family": "Kaeuffer", "given": "C Charlotte", "sequence": "additional" }, { "affiliation": [], "family": "Danion", "given": "François", "sequence": "additional" }, { "affiliation": [], "family": "Hansmann", "given": "Yves", "sequence": "additional" }, { "affiliation": [], "family": "Lefebvre", "given": "Nicolas", "sequence": "additional" }, { "affiliation": [], "family": "Ruch", "given": "Yvon", "sequence": "additional" }, { "affiliation": [], "family": "Ursenbach", "given": "Axel", "sequence": "additional" }, { "affiliation": [], "family": "Schmidt-Mutter", "given": "Catherine", "sequence": "additional" }, { "affiliation": [], "family": "Suliman", "given": "Muhtadi", "sequence": "additional" }, { "affiliation": [], "family": "Hutt", "given": "Anne", "sequence": "additional" }, { "affiliation": [], "family": "Becker", "given": "Guillaume", "sequence": "additional" }, { "affiliation": [], "family": "Laugel", "given": "Elodie", "sequence": "additional" }, { "affiliation": [], "family": "Bayer", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Dubee", "given": "Vincent", "sequence": "additional" }, { "affiliation": [], "family": "Mahieu", "given": "Rafael", "sequence": "additional" }, { "affiliation": [], "family": "Daniel", "given": "Valérie", "sequence": "additional" }, { "affiliation": [], "family": "Lefeuvre", "given": "Caroline", "sequence": "additional" }, { "affiliation": [], "family": "Ducancelle", "given": "Alexandra", "sequence": "additional" }, { "affiliation": [], "family": "Gagnard", "given": "Jean-Charles", "sequence": "additional" }, { "affiliation": [], "family": "Mohebbi", "given": "Abolfzl", "sequence": "additional" }, { "affiliation": [], "family": "Dehais", "given": "Mélanie", "sequence": "additional" }, { "affiliation": [], "family": "Raccah", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Pouliquen", "given": "Anne-Lise", "sequence": "additional" }, { "affiliation": [], "family": "Klasen", "given": "Alison", "sequence": "additional" }, { "affiliation": [], "family": "Forestier", "given": "Emmanuel", "sequence": "additional" }, { "affiliation": [], "family": "Carret", "given": "Marie-Christine", "sequence": "additional" }, { "affiliation": [], "family": "Liardot", "given": "Severine", "sequence": "additional" }, { "affiliation": [], "family": "Grosjean", "given": "Jérôme", "sequence": "additional" }, { "affiliation": [], "family": "Faucher", "given": "Jean-François", "sequence": "additional" }, { "affiliation": [], "family": "Brisset", "given": "Josselin", "sequence": "additional" }, { "affiliation": [], "family": "Cypierre", "given": "Anne", "sequence": "additional" }, { "affiliation": [], "family": "Durox", "given": "Hélène", "sequence": "additional" }, { "affiliation": [], "family": "Pinet", "given": "Pauline", "sequence": "additional" }, { "affiliation": [], "family": "Ducroix-Roubertou", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Genet", "given": "Claire", "sequence": "additional" }, { "affiliation": [], "family": "Vallejo", "given": "Christine", "sequence": "additional" }, { "affiliation": [], "family": "Hantz", "given": "Sébastien", "sequence": "additional" }, { "affiliation": [], "family": "Gousseff", "given": "Marie", "sequence": "additional" }, { "affiliation": [], "family": "Merlet", "given": "Antoine", "sequence": "additional" }, { "affiliation": [], "family": "Bigot", "given": "Sébastien", "sequence": "additional" }, { "affiliation": [], "family": "Girard De Courtilles", "given": "Marion", "sequence": "additional" }, { "affiliation": [], "family": "Pouedras", "given": "Pascal", "sequence": "additional" }, { "affiliation": [], "family": "Lariviere", "given": "Delphine", "sequence": "additional" }, { "affiliation": [], "family": "Verdon", "given": "Renaud", "sequence": "additional" }, { "affiliation": [], "family": "Dargere", "given": "Sylvie", "sequence": "additional" }, { "affiliation": [], "family": "Michon", "given": "Jocelyn", "sequence": "additional" }, { "affiliation": [], "family": "Fournier", "given": "Anna", "sequence": "additional" }, { "affiliation": [], "family": "Brucato", "given": "Sylvie", "sequence": "additional" }, { "affiliation": [], "family": "Gautier", "given": "Séverine", "sequence": "additional" }, { "affiliation": [], "family": "Valentin", "given": "Cécile", "sequence": "additional" }, { "affiliation": [], "family": "Ricci", "given": "Anne", "sequence": "additional" }, { "affiliation": [], "family": "Alix", "given": "Antoine", "sequence": "additional" }, { "affiliation": [], "family": "Lacassin-Beller", "given": "Flore", "sequence": "additional" }, { "affiliation": [], "family": "Rousseau", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Dimet", "given": "Jérôme", "sequence": "additional" }, { "affiliation": [], "family": "Boivin", "given": "Anne-Hélène", "sequence": "additional" }, { "affiliation": [], "family": "Larregle", "given": "Maylis", "sequence": "additional" }, { "affiliation": [], "family": "Rousseau", "given": "Guillaume", "sequence": "additional" }, { "affiliation": [], "family": "Assaf", "given": "Ady", "sequence": "additional" }, { "affiliation": [], "family": "Vuotto", "given": "Fanny", "sequence": "additional" }, { "affiliation": [], "family": "Faure", "given": "Karine", "sequence": "additional" }, { "affiliation": [], "family": "Joachim", "given": "Camille", "sequence": "additional" }, { "affiliation": [], "family": "Bocket", "given": "Laurence", "sequence": "additional" }, { "affiliation": [], "family": "Diallo", "given": "Kévin", "sequence": "additional" }, { "affiliation": [], "family": "Saffore", "given": "Jessy", "sequence": "additional" }, { "affiliation": [], "family": "Madeline", "given": "Isabelle", "sequence": "additional" }, { "affiliation": [], "family": "Chabanon", "given": "Pauline", "sequence": "additional" }, { "affiliation": [], "family": "Allou", "given": "Nathalie", "sequence": "additional" }, { "affiliation": [], "family": "Fernandes", "given": "Elisabeth", "sequence": "additional" }, { "affiliation": [], "family": "Gruliere", "given": "Anne-Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Botelho-Nevers", "given": "Elisabeth", "sequence": "additional" }, { "affiliation": [], "family": "Gagneux-Brunon", "given": "Amandine", "sequence": "additional" }, { "affiliation": [], "family": "Ronat", "given": "Véronique", "sequence": "additional" }, { "affiliation": [], "family": "Casimir", "given": "Nadine", "sequence": "additional" }, { "affiliation": [], "family": "Pillet", "given": "Sylvie", "sequence": "additional" }, { "affiliation": [], "family": "Bertholon", "given": "Frédérique", "sequence": "additional" }, { "affiliation": [], "family": "Pialloux", "given": "Gilles", "sequence": "additional" }, { "affiliation": [], "family": "Bachir Elrufaai", "given": "Marwa", "sequence": "additional" }, { "affiliation": [], "family": "Calin", "given": "Ruxandra", "sequence": "additional" }, { "affiliation": [], "family": "Thibaut", "given": "Pélagie", "sequence": "additional" }, { "affiliation": [], "family": "Tendjaoui", "given": "Fatima", "sequence": "additional" }, { "affiliation": [], "family": "Fillon", "given": "Julie", "sequence": "additional" }, { "affiliation": [], "family": "Morand-Joubert", "given": "Laurence", "sequence": "additional" }, { "affiliation": [], "family": "Vareil", "given": "Marc-Olivier", "sequence": "additional" }, { "affiliation": [], "family": "Wille", "given": "Heidi", "sequence": "additional" }, { "affiliation": [], "family": "Menager", "given": "Philippe", "sequence": "additional" }, { "affiliation": [], "family": "Cordel", "given": "Hugues", "sequence": "additional" }, { "affiliation": [], "family": "Mohammed-Kassim", "given": "Youssouf", "sequence": "additional" }, { "affiliation": [], "family": "Rathouin", "given": "Vanessa", "sequence": "additional" }, { "affiliation": [], "family": "Brichler", "given": "Ségolène", "sequence": "additional" }, { "affiliation": [], "family": "Cabie", "given": "André", "sequence": "additional" }, { "affiliation": [], "family": "Lehoux", "given": "Mélanie", "sequence": "additional" }, { "affiliation": [], "family": "Guitteaud", "given": "Karine", "sequence": "additional" }, { "affiliation": [], "family": "Sylla", "given": "Karamba", "sequence": "additional" }, { "affiliation": [], "family": "Bigeard", "given": "Bastien", "sequence": "additional" }, { "affiliation": [], "family": "Campana", "given": "Valentine", "sequence": "additional" }, { "affiliation": [], "family": "Calmont", "given": "Isabelle", "sequence": "additional" }, { "affiliation": [], "family": "Lamaignere", "given": "Jean-Louis", "sequence": "additional" }, { "affiliation": [], "family": "Deppenweiller", "given": "Marine", "sequence": "additional" }, { "affiliation": [], "family": "Padoin", "given": "Christophe", "sequence": "additional" }, { "affiliation": [], "family": "Thilbault", "given": "Marine", "sequence": "additional" }, { "affiliation": [], "family": "Fagour", "given": "Laurence", "sequence": "additional" }, { "affiliation": [], "family": "Najioullah", "given": "Fatiha", "sequence": "additional" }, { "affiliation": [], "family": "Komla-Soukha", "given": "Isabelle", "sequence": "additional" }, { "affiliation": [], "family": "Roncato-Saberan", "given": "Mariam", "sequence": "additional" }, { "affiliation": [], "family": "Martinot", "given": "Martin", "sequence": "additional" }, { "affiliation": [], "family": "Mohseni Zadeh", "given": "Mahsa", "sequence": "additional" }, { "affiliation": [], "family": "Gravier", "given": "Simon", "sequence": "additional" }, { "affiliation": [], "family": "Ion", "given": "Ciprian", "sequence": "additional" }, { "affiliation": [], "family": "Kayser", "given": "Damien", "sequence": "additional" }, { "affiliation": [], "family": "Schieber Pachart", "given": "Anne", "sequence": "additional" }, { "affiliation": [], "family": "Eyriey", "given": "Magali", "sequence": "additional" }, { "affiliation": [], "family": "Henric", "given": "Anaïs", "sequence": "additional" }, { "affiliation": [], "family": "Daniel Kaiser", "given": "Jean", "sequence": "additional" }, { "affiliation": [], "family": "De Briel", "given": "Dominique", "sequence": "additional" }, { "affiliation": [], "family": "Duvaux", "given": "Odile", "sequence": "additional" }, { "affiliation": [], "family": "Evanno", "given": "Gwenaëlle", "sequence": "additional" }, { "affiliation": [], "family": "Royer", "given": "Pierre-Joseph", "sequence": "additional" }, { "affiliation": [], "family": "Rousse", "given": "Juliette", "sequence": "additional" }, { "affiliation": [], "family": "Ciron", "given": "Carine", "sequence": "additional" }, { "affiliation": [], "family": "Lhériteau", "given": "Elsa", "sequence": "additional" }, { "affiliation": [], "family": "Rouvray", "given": "Gaëtane", "sequence": "additional" }, { "affiliation": [], "family": "Mougeolle", "given": "Alan", "sequence": "additional" }, { "affiliation": [], "family": "Rillet", "given": "Auriane", "sequence": "additional" }, { "affiliation": [], "family": "Despons", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "Mevel", "given": "Edwige", "sequence": "additional" }, { "affiliation": [], "family": "Shneiker", "given": "Françoise", "sequence": "additional" }, { "affiliation": [], "family": "Josien", "given": "Régis", "sequence": "additional" }, { "affiliation": [], "family": "Braudeau", "given": "Cécile", "sequence": "additional" }, { "affiliation": [], "family": "Brouard", "given": "Sophie", "sequence": "additional" }, { "affiliation": [], "family": "le Mai", "given": "Hoa", "sequence": "additional" }, { "affiliation": [], "family": "Appau-Danquah", "given": "Elise", "sequence": "additional" }, { "affiliation": [], "family": "Daniel", "given": "Amélie", "sequence": "additional" }, { "affiliation": [], "family": "Grybek", "given": "Virginie", "sequence": "additional" }, { "affiliation": [], "family": "Gueneau", "given": "David", "sequence": "additional" }, { "affiliation": [], "family": "Gautier", "given": "Marion", "sequence": "additional" }, { "affiliation": [], "family": "Martin-Gauthier", "given": "Joëlle", "sequence": "additional" }, { "affiliation": [], "family": "Rebouilleau", "given": "Emily", "sequence": "additional" }, { "affiliation": [], "family": "Herault", "given": "Joseph", "sequence": "additional" }, { "affiliation": [], "family": "Roman", "given": "Tanguy", "sequence": "additional" }, { "affiliation": [], "family": "Plantard", "given": "Sorady", "sequence": "additional" }, { "affiliation": [], "family": "Chauveau", "given": "Patrice", "sequence": "additional" }, { "affiliation": [], "family": "Chiffoleau", "given": "Anne", "sequence": "additional" }, { "affiliation": [], "family": "Thauvin", "given": "Stéphanie", "sequence": "additional" }, { "affiliation": [], "family": "Flet", "given": "Laurent", "sequence": "additional" }, { "affiliation": [], "family": "Tching-Sin", "given": "Martine", "sequence": "additional" }, { "affiliation": [], "family": "Clapeau", "given": "Eugenie", "sequence": "additional" }, { "affiliation": [], "family": "Charreau", "given": "Isabelle", "sequence": "additional" }, { "affiliation": [], "family": "Hoen", "given": "Bruno", "sequence": "additional" }, { "affiliation": [], "family": "Solas-Chesneau", "given": "Caroline", "sequence": "additional" }, { "affiliation": [], "family": "Vabret", "given": "Astrid", "sequence": "additional" }, { "affiliation": [], "name": "for the POLYCOR study group", "sequence": "additional" } ], "container-title": "Open Forum Infectious Diseases", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2023, 10, 20 ] ], "date-time": "2023-10-20T22:37:00Z", "timestamp": 1697841420000 }, "deposited": { "date-parts": [ [ 2023, 11, 7 ] ], "date-time": "2023-11-07T14:53:43Z", "timestamp": 1699368823000 }, "funder": [ { "name": "Nantes University Hospital Research" }, { "DOI": "10.13039/100016308", "doi-asserted-by": "publisher", "name": "Public Investment Bank" } ], "indexed": { "date-parts": [ [ 2023, 11, 8 ] ], "date-time": "2023-11-08T00:41:31Z", "timestamp": 1699404091574 }, "is-referenced-by-count": 0, "issue": "11", "issued": { "date-parts": [ [ 2023, 10, 20 ] ] }, "journal-issue": { "issue": "11", "published-print": { "date-parts": [ [ 2023, 11, 1 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 10, 20 ] ], "date-time": "2023-10-20T00:00:00Z", "timestamp": 1697760000000 } } ], "link": [ { "URL": "https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofad525/52316723/ofad525.pdf", "content-type": "application/pdf", "content-version": "am", "intended-application": "syndication" }, { "URL": "https://academic.oup.com/ofid/article-pdf/10/11/ofad525/52777270/ofad525.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication" }, { "URL": "https://academic.oup.com/ofid/article-pdf/10/11/ofad525/52777270/ofad525.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "286", "original-title": [], "prefix": "10.1093", "published": { "date-parts": [ [ 2023, 10, 20 ] ] }, "published-online": { "date-parts": [ [ 2023, 10, 20 ] ] }, "published-other": { "date-parts": [ [ 2023, 11 ] ] }, "published-print": { "date-parts": [ [ 2023, 11, 1 ] ] }, "publisher": "Oxford University Press (OUP)", "reference": [ { "DOI": "10.1001/jama.2020.2648", "article-title": "Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention", "author": "Wu", "doi-asserted-by": "crossref", "first-page": "1239", "journal-title": "JAMA", "key": "2023110713384883800_ofad525-B1", "volume": "323", "year": "2020" }, { "DOI": "10.1016/j.chest.2022.02.006", "article-title": "Thromboprophylaxis in patients with COVID-19: a brief update to the CHEST guideline and expert panel report", "author": "Moores", "doi-asserted-by": "crossref", "first-page": "213", "journal-title": "Chest", "key": "2023110713384883800_ofad525-B2", "volume": "162", "year": "2022" }, { "DOI": "10.1016/S1473-3099(21)00485-0", "article-title": "Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial", "author": "Ader", "doi-asserted-by": "crossref", "first-page": "209", "journal-title": "Lancet Infect Dis", "key": "2023110713384883800_ofad525-B3", "volume": "22", "year": "2022" }, { "DOI": "10.1001/jama.2020.17023", "article-title": "Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis", "author": "WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group", "doi-asserted-by": "crossref", "first-page": "1330", "journal-title": "JAMA", "key": "2023110713384883800_ofad525-B4", "volume": "324", "year": "2020" }, { "DOI": "10.1016/j.cmi.2022.07.008", "article-title": "Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis", "author": "Albuquerque", "doi-asserted-by": "crossref", "first-page": "13", "journal-title": "Clin Microbiol Infect", "key": "2023110713384883800_ofad525-B5", "volume": "29", "year": "2023" }, { "DOI": "10.1056/NEJMoa2101643", "article-title": "Tofacitinib in patients hospitalized with COVID-19 pneumonia", "author": "Guimarães", "doi-asserted-by": "crossref", "first-page": "406", "journal-title": "N Engl J Med", "key": "2023110713384883800_ofad525-B6", "volume": "385", "year": "2021" }, { "DOI": "10.1001/jama.2022.2832", "article-title": "Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial", "author": "Gupta", "doi-asserted-by": "crossref", "first-page": "1236", "journal-title": "JAMA", "key": "2023110713384883800_ofad525-B7", "volume": "327", "year": "2022" }, { "article-title": "A living WHO guideline on drugs for COVID-19", "author": "Agarwal", "first-page": "m3379", "journal-title": "BMJ", "key": "2023110713384883800_ofad525-B8", "volume": "370", "year": "2020" }, { "DOI": "10.2807/1560-7917.ES.2021.26.26.2100557", "article-title": "Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel", "author": "Lustig", "doi-asserted-by": "crossref", "first-page": "2100557", "journal-title": "Euro Surveill", "key": "2023110713384883800_ofad525-B9", "volume": "26", "year": "2021" }, { "DOI": "10.1093/cid/ciac601", "article-title": "Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the severe acute respiratory syndrome coronavirus 2 Omicron variant", "author": "Huygens", "doi-asserted-by": "crossref", "first-page": "e507", "journal-title": "Clin Infect Dis", "key": "2023110713384883800_ofad525-B10", "volume": "76", "year": "2023" }, { "DOI": "10.1038/nrmicro974", "article-title": "Passive antibody therapy for infectious diseases", "author": "Casadevall", "doi-asserted-by": "crossref", "first-page": "695", "journal-title": "Nat Rev Microbiol", "key": "2023110713384883800_ofad525-B11", "volume": "2", "year": "2004" }, { "DOI": "10.1002/eji.202049072", "article-title": "High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2", "author": "Vanhove", "doi-asserted-by": "crossref", "first-page": "1412", "journal-title": "Eur J Immunol", "key": "2023110713384883800_ofad525-B12", "volume": "51", "year": "2021" }, { "DOI": "10.1101/2022.01.26.477856", "article-title": "Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)", "author": "Vanhove", "doi-asserted-by": "crossref", "key": "2023110713384883800_ofad525-B13", "volume-title": "bioRxiv", "year": "2022" }, { "DOI": "10.1186/s13063-021-05132-9", "article-title": "Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial", "author": "Gaborit", "doi-asserted-by": "crossref", "first-page": "199", "journal-title": "Trials", "key": "2023110713384883800_ofad525-B14", "volume": "22", "year": "2021" }, { "DOI": "10.1128/AAC.01237-21", "article-title": "Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study", "author": "Gaborit", "doi-asserted-by": "crossref", "first-page": "e0123721", "journal-title": "Antimicrob Agents Chemother", "key": "2023110713384883800_ofad525-B15", "volume": "65", "year": "2021" }, { "author": "COVID-19 map", "key": "2023110713384883800_ofad525-B16" }, { "DOI": "10.1038/s41587-020-0631-z", "article-title": "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction", "author": "Tan", "doi-asserted-by": "crossref", "first-page": "1073", "journal-title": "Nat Biotechnol", "key": "2023110713384883800_ofad525-B17", "volume": "38", "year": "2020" }, { "DOI": "10.1084/jem.193.7.803", "article-title": "Glucocorticoids attenuate T cell receptor signaling", "author": "Van Laethem", "doi-asserted-by": "crossref", "first-page": "803", "journal-title": "J Exp Med", "key": "2023110713384883800_ofad525-B18", "volume": "193", "year": "2001" }, { "DOI": "10.1016/S0140-6736(20)32013-4", "article-title": "Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial", "author": "RECOVERY Collaborative Group", "doi-asserted-by": "crossref", "first-page": "1345", "journal-title": "Lancet Lond Engl", "key": "2023110713384883800_ofad525-B19", "volume": "396", "year": "2020" }, { "DOI": "10.1056/NEJMoa2021436", "article-title": "Dexamethasone in hospitalized patients with COVID-19", "author": "RECOVERY Collaborative Group", "doi-asserted-by": "crossref", "first-page": "693", "journal-title": "N Engl J Med", "key": "2023110713384883800_ofad525-B20", "volume": "384", "year": "2021" }, { "DOI": "10.1016/S0140-6736(21)00676-0", "article-title": "Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial", "author": "RECOVERY Collaborative Group", "doi-asserted-by": "crossref", "first-page": "1637", "journal-title": "Lancet Lond Engl", "key": "2023110713384883800_ofad525-B21", "volume": "397", "year": "2021" }, { "DOI": "10.1016/S0140-6736(21)00897-7", "article-title": "Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial", "author": "RECOVERY Collaborative Group", "doi-asserted-by": "crossref", "first-page": "2049", "journal-title": "Lancet Lond Engl", "key": "2023110713384883800_ofad525-B22", "volume": "397", "year": "2021" }, { "DOI": "10.1016/S0140-6736(22)00163-5", "article-title": "Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial", "author": "RECOVERY Collaborative Group", "doi-asserted-by": "crossref", "first-page": "665", "journal-title": "Lancet Lond Engl", "key": "2023110713384883800_ofad525-B23", "volume": "399", "year": "2022" }, { "DOI": "10.1016/S1473-3099(22)00295-X", "article-title": "Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19", "author": "Ader", "doi-asserted-by": "crossref", "first-page": "764", "journal-title": "Lancet Infect Dis", "key": "2023110713384883800_ofad525-B24", "volume": "22", "year": "2022" }, { "DOI": "10.1056/NEJMoa2108163", "article-title": "REGEN-COV antibody combination and outcomes in outpatients with COVID-19", "author": "Weinreich", "doi-asserted-by": "crossref", "first-page": "e81", "journal-title": "N Engl J Med", "key": "2023110713384883800_ofad525-B25", "volume": "385", "year": "2021" }, { "DOI": "10.3389/fimmu.2021.761250", "article-title": "XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants", "author": "Vanhove", "doi-asserted-by": "crossref", "first-page": "761250", "journal-title": "Front Immunol", "key": "2023110713384883800_ofad525-B26", "volume": "12", "year": "2021" }, { "DOI": "10.4161/mabs.23684", "article-title": "Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human", "author": "Shah", "doi-asserted-by": "crossref", "first-page": "297", "journal-title": "mAbs", "key": "2023110713384883800_ofad525-B27", "volume": "5", "year": "2013" }, { "DOI": "10.1016/j.xphs.2017.03.033", "article-title": "Tissue distribution of a therapeutic monoclonal antibody determined by large pore microdialysis", "author": "Jadhav", "doi-asserted-by": "crossref", "first-page": "2853", "journal-title": "J Pharm Sci", "key": "2023110713384883800_ofad525-B28", "volume": "106", "year": "2017" }, { "DOI": "10.1002/cpt.2420", "article-title": "Population pharmacokinetics and pharmacodynamics of the neutralizing antibodies bamlanivimab and etesevimab in patients with mild to moderate COVID-19 infection", "author": "Chigutsa", "doi-asserted-by": "crossref", "first-page": "1302", "journal-title": "Clin Pharmacol Ther", "key": "2023110713384883800_ofad525-B29", "volume": "110", "year": "2021" }, { "DOI": "10.1016/j.chest.2022.06.029", "article-title": "Neutralizing COVID-19 convalescent plasma in adults hospitalized with COVID-19: a blinded, randomized, placebo-controlled trial", "author": "Self", "doi-asserted-by": "crossref", "first-page": "982", "journal-title": "Chest", "key": "2023110713384883800_ofad525-B30", "volume": "162", "year": "2022" }, { "article-title": "Convalescent plasma for people with COVID-19: a living systematic review", "author": "Iannizzi", "first-page": "CD013600", "journal-title": "Cochrane Database Syst Rev", "key": "2023110713384883800_ofad525-B31", "volume": "2", "year": "2023" }, { "DOI": "10.1093/infdis/jiad393", "article-title": "Nirmatrelvir/ritonavir use and hospitalizations or death in previously uninfected non-hospitalized high-risk population with COVID-19: a matched cohort study", "author": "Butt", "doi-asserted-by": "publisher", "journal-title": "J Infect Dis.", "key": "2023110713384883800_ofad525-B32", "year": "2023" } ], "reference-count": 32, "references-count": 32, "relation": {}, "resource": { "primary": { "URL": "https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofad525/7325964" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Infectious Diseases", "Oncology" ], "subtitle": [], "title": "Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial", "type": "journal-article", "volume": "10" }
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit